Literature DB >> 22847498

Thrombopoietin receptor agonists in the treatment of immune thrombocytopenia: a clinician's perspective.

Marco Ruggeri1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847498     DOI: 10.1002/ajh.23298

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.

Authors:  Reiko Watanabe; Takayuki Tabayashi; Tatsuki Tomikawa; Morihiko Sagawa; Tomoe Anan-Nemoto; Yuta Kimura; Yasuyuki Takahashi; Michihide Tokuhira; Satoshi Otaki; Hidenori Oi; Makoto Sawano; Satoshi Sugiyama; Masahiro Kizaki
Journal:  Int J Hematol       Date:  2016-10-05       Impact factor: 2.490

2.  Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.

Authors:  Mohamed E Osman
Journal:  Sudan J Paediatr       Date:  2012
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.